Belpointe Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-105	Closed	-$21K	–	701
2023 Q1	$21K	Sell	105 -2	-2%	-$401	﹤0.01%	2286
2022 Q4	$25.4K	Buy	+107	New	+$25.4K	﹤0.01%	2011
2022 Q2	–	Sell	-670	Closed	-$110K	–	1132
2022 Q1	$110K	Buy	+670	New	+$110K	0.01%	1170